Johnson & Johnson Earnings Beat Boosted by Hepatitis Drug - Presented by: The Aol. On Network

Shares of Johnson & Johnson are in focus on Tuesday after the company posted second quarter results which were better than what Wall Street was expecting. Johnson & Johnson says sales around the world were strong. Excluding one time charges, J&J earned $1.66 a share, that's more than 10 cents better than expectations. Revenue for the quarter was $19.5 billion, slightly better than expectations and a 9 percent increase compared to the same period a year ago.



Related Videos

Most Popular Videos

Latest Videos



Most Active by Volume

Company Last Sale Change Net / %
BAC $ 23.88 0.61 ▲ 2.62%
RAD $ 3.93 0.19 ▲ 5.08%
QQQ $ 140.02 1.99 ▲ 1.44%
CBI $ 20.21 0.19 ▲ 0.95%
GE $ 27.08 0.13 ▼ 0.48%
F $ 11.09 0.01 ▲ 0.09%
P $ 8.92 0.43 ▲ 5.06%
MU $ 32.24 0.58 ▲ 1.83%

As of 6/28/2017, 04:15 PM








Cybersecurity